2Conh G, Valdes G,Capuzzi DM. Pathophysiology and treatment of the dyslipidemia of insulin resistance[J]. Curr Cardiol Rep, 2001,3(5) :416-423.
3Najarian RM, Sullivan LM, Kannel WB, et al. Metabolic syndrome compared with type 2 diabetes mellitus as a risk factor for stroke:the Framingham Offspring Study[J]. Arch Intern Med,2006,166(1) :106-111.
4Groop L,Orho-Melander M. The dysmetabolic syndrome[J]. J Intern Med,2001,250(2): 105-120.
5Nash DT. Relationship of C-reactive protein, metabolic syndrome and diabetes mellitus: potential role of statins[J]. J Natl Med Assoc,2005,97(12) :1600-1607.
6Cohn G, Valdes G, Capuzzi DM. Pathophysiology and treatment of the dyslipidemia of insulin resistance [J]. Curt Cardiol Rep,2001,3(5) :416-423.
7Isomaa B, Aimgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome[J]. Diabetes Care, 2001,24 (4) : 683-689.
8Ninomiya JK, L Italien G,Criqui MH, et al. Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey[J]. Circulation, 2004,109 (1) : 42-46.
9Smadja D, Cabre P, May F, et al. ERMANCIA:Epidemiology of Stroke in Martinique, Frenth West Indies. Part Ⅰ: methodology, incidence, and 30-day case fatality rate[J].Stroke,2001,32(12):2741-2747.
10Tanaka H, Ueda Y, Hayashi M, et al. Risk factors for cerebral hemorrhage and cerebral infarction in a Japanese rural conununity[J].Stroke,1982,13(1):62-73.
